Tobacco smoke affects expression of peroxisome proliferator-activated receptor-γ in monocyte/macrophages of patients with coronary heart disease

British Journal of Pharmacology

Volumn 158, Issue 5, 2009, Pages 1276-1284

  Amoruso, A ^a   Gunella, G ^a   Rondano, E ^a   Bardelli, C ^a   Fresu, L G ^a   Ferrero, V ^b   Ribichini, F ^b   Vassanelli, C ^b   Brunelleschi, S ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Coronary heart diseases; Cytokines; Monocyte macrophages; Nf b; Ppar ; Tobacco smoke

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ACTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NITRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHORBOL 13 ACETATE 12 MYRISTATE; ROSIGLITAZONE; TOBACCO SMOKE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING HABIT; WESTERN BLOTTING;

ACTINS; AGED; CELL DIFFERENTIATION; CORONARY DISEASE; CYTOKINES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIGANDS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; PPAR GAMMA; SMOKE; THIAZOLIDINEDIONES; TOBACCO;

EID: 70849125991     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00442.x     Document Type: Article

References (26)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2): S1-S209.
2. Amoruso A, Bardelli C, Gunella G, Fresu LG, Ferrero V, Brunelleschi S (2007). Quantification of PPARgamma protein in monocyte/ macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine. Life Sci 81: 906-915. (Pubitemid 47374210)
3. Amoruso A, Bardelli C, Gunella G, Ribichini F, Brunelleschi S (2008). A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-y protein expression in human monocytes and macrophages. Br f Pharmacol 154: 144-152. (Pubitemid 351620392)
4. 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-κB pathway. Br J Pharmacol 145: 385-396.
5. Benowitz NL (2008). Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83: 531-541.
6. Blake GJ, Ridker PM (2002). Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 252: 283-294. (Pubitemid 35253696)
7. Brown DW, Mensah GA (2007). Smoking among adults with coronary heart disease. Prev Med 44: 85-86. (Pubitemid 46073079)
8. 2, PPARy agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocyte/macrophages. Antioxid Redox Signal 10: 253-260.
9. Chiolero A, Faeh D, Paccaud F, Cornuz J (2008). Consequences of smoking for body weight, body fat distribution and insulin resistance. Am f Clin Nutr 87: 801-809. (Pubitemid 351549222)
10. Cox PJ, Ryan DA, Hollis FJ, Harris AM, Miller AK, Vousden M et al. (2000). Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans. Drug Metab Dispos 28: 772-780. (Pubitemid 30470827)
11. Gunella G, Bardelli C, Amoruso A, Viano I, Balbo P, Brunelleschi S (2006). Macrophage stimulating protein (MSP) differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-κB pathway. Br f Pharmacol 148: 478-489. (Pubitemid 43882084)
12. Jiang C, Ting AT, Seed B (1998). PPARy agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86. (Pubitemid 28079219)
13. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ et al. (2006). Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res 7: 66 (doi: 10.1186/1465-9921-7-66 PMID: 16620395). (Pubitemid 43959888)
14. Lavagno L, Gunella G, Bardelli C, Spina S, Fresu LG, Viano I et al. (2004). Anti-inflammatory drugs and tumour necrosis factor-alpha production from monocytes: role of transcription factor NF-kappaB and implication for rheumatoid arthritis therapy. Eur f Pharmacol 501: 199-208. (Pubitemid 39298953)
15. Lee SY, Kang EJ, Hur GY, Jung KH, Jung CH, Lee SY et al. (2006). Peroxisome proliferator-activated receptor gamma inhibits cigarette-smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells. Am J Physiol 291: L84-90.
16. Li AC, Palinski W (2006). Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis. Annu Rev Pharmacol Toxicol 46: 1-39.
17. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK (2000). Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106: 523-531. (Pubitemid 30666385)
18. Nissen SE, Wolski K (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular risk. N Engl J Med 356: 2457-2471. (Pubitemid 46919772)
19. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82. (Pubitemid 28079218)
20. Ridker PM, Rifai N, Stamfer MJ, Hennekens CH (2000). Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767-1772. (Pubitemid 30213096)
21. Rigamonti E, Chinetti-Gbaguidi G, Staels B (2008). Regulation of macrophage functions by PPARa, PPARy, and LXRs in mice and men. Arterioscler Thromb Vase Biol 28: 1050-1059.
22. Skoog T, Dichtl W, Skoglund-Andersson C, Karpe F, Tang R, Bond MG et al. (2002). Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 23: 376383. (Pubitemid 35204198)
23. Straus DS, Glass CK (2007). Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28: 551-558. (Pubitemid 350101420)
24. Szanto A, Roszer T (2008). Nuclear receptors in macrophages: a link between metabolism and inflammation. FEBS Lett 582: 106116. (Pubitemid 350297244)
25. Taylor BV, Oudit GY, Kaalman PG, Liu P (1998). Clinical and pathophysiological effects of active and passive smoking on cardiovascular system. Can J Cardiol 14: 1129-1139.
26. Thompson PW, Bayliffe AI, Warren AP, Lamb JR (2007). Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4 + T cells. Cytokine 39: 184-191.